Super Micro Computer (NASDAQ: SMCI) and Aehr Test Systems (NASDAQ: AEHR) both serve the artificial intelligence sector but operate at vastly different scales and risk levels.
Aehr designs specialized test and burn-in solutions for semiconductor devices used in electric vehicles, artificial intelligence, and telecommunications applications.
Super Micro builds rack-scale IT infrastructure that powers enterprise data centers, cloud computing platforms, and edge computing deployments worldwide.
Both companies are central to the global computing shift driven by AI demand, but their recent financial performance tells very different stories.
Aehr posted fiscal year 2026 revenue of $50.0 million, representing a decline of 15.2% compared to the prior year, with a net loss of $7.1 million recorded over that period.
The company’s net margin came in at -14.3% for the year, and free cash flow was negative $5.4 million, though its balance sheet remains debt-free with a current ratio of 10.3x.
Five customers accounted for 70% of Aehr’s net sales in its fiscal 2026 year ended May 29, creating meaningful concentration risk that could materially harm results if one major client exits.
Super Micro reported fiscal year 2026 revenue of $39.1 billion, reflecting extraordinary growth of 77.8% year-over-year for the period ended June 30.
Net income for Super Micro reached $2.2 billion during that same fiscal year, with a net margin of 5.7% demonstrating that the company can generate profit at scale despite heavy investment.
The company carries a current ratio of 3.9x and a debt-to-equity ratio of 0.6x, though free cash flow was negative $7 billion as it pours capital into inventory and manufacturing capacity.
Super Micro competes with major technology vendors and remains sensitive to component pricing from Nvidia (NASDAQ: NVDA) and Intel (NASDAQ: INTC), both of which supply critical hardware.
The company has also faced significant legal and reputational headwinds, including class action lawsuits over potential accounting issues and its stock nearly being delisted for failing to file required earnings reports on time.
This year, former employees were indicted in connection with an alleged conspiracy to commit export-control violations in an attempt to smuggle AI tech to China, further clouding the company’s public image.
Despite these controversies, Super Micro’s valuation remains compelling, with a Forward P/E of just 9.9x and a P/S ratio of 0.6x compared to Aehr’s Forward P/E of 117.7x and P/S ratio of 55.5x.
Aehr’s sales have experienced volatile swings over recent quarters, and its lack of profitability despite operating in the hot AI market remains a key concern for investors evaluating the stock.
Robert Izquierdo, the analyst behind this comparison, stated a preference for Super Micro and disclosed a personal investment in the company based on its growth trajectory and valuation.
Geopolitical risks tied to trade relations with China and Taiwan also present supply chain exposure for Aehr, adding another layer of uncertainty to an already volatile revenue picture.
Super Micro’s 78% year-over-year revenue growth in fiscal 2026 signals that demand for its AI infrastructure solutions remains robust despite the legal and regulatory challenges surrounding the business.
For investors weighing these two AI-adjacent stocks, Super Micro’s combination of massive revenue scale, reasonable valuation, and dominant market positioning appears to outweigh its well-documented controversies.
Aehr plays a legitimate role in the AI ecosystem as a semiconductor component tester, but its financial profile and customer concentration make it a higher-risk choice relative to Super Micro at current levels.
